Performance of studies in support of the CET-raidir program.

Active Awarded Last action

Contract number
W911SR23F0049
Awardee
Awarding agency
Obligated
$23,702,221

Award facts

Contract value 48% obligated
$49,500,000.00 Current and potential, with all options
Completion date 75% complete
Current and potential, with all options
Contracting staff
Funding agency
Joint PEO Chemical and Biological Defense Acquisition Support Center, Department of Defense
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
Pricing
Cost Plus Fixed Fee
Place of performance
Columbus, OH 43201, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Supplemental Agreement for work within scope P00030 · The purpose of this modification is to incorporate an ebola study under clin 0002, approve BOT MAB manuscript under clin 0002, and provide incremental funding… $797,819
Funding Only Action P00029 $596,715
Other Administrative Action P00028 -$321,000
Supplemental Agreement for work within scope P00027 $1,133,401
Funding Only Action P00026 -$252,102
Funding Only Action P00025 $676,869
Funding Only Action P00024 $957,541
Supplemental Agreement for work within scope P00023 $333,888
Funding Only Action P00022 $2,261,474
Funding Only Action P00021 · The purpose of this modification is to provide incremental funding to clin 0002 and clin 0006 under delivery order W911SR-23-F-0049. See summary of changes. $3,259,512
Funding Only Action P00020 $2,875,114
Funding Only Action P00019 $20,000
Supplemental Agreement for work within scope P00018 $1,504,922
Supplemental Agreement for work within scope P00017 $631,579
Funding Only Action P00016 $754,357
Supplemental Agreement for work within scope P00015 $1,065,947
Other Administrative Action P00014 $0
Other Administrative Action P00013 $0
Supplemental Agreement for work within scope P00012 $1,773,527
Supplemental Agreement for work within scope P00011 $236,822
Supplemental Agreement for work within scope P00010 · To design and conduct nonclinical research studies, develop supporting assays and reagents, interpret and report study results and analysis, and evaluate… $946,073
Funding Only Action P00009 $201,230
Funding Only Action P00008 · Non-clnical studies $517,055
Funding Only Action P00007 · Countering emerging threats rapid acquisition and investigation of drugs for repurposing development support studies. $262,865
Supplemental Agreement for work within scope P00006 $282,236
Supplemental Agreement for work within scope P00005 $460,891
Supplemental Agreement for work within scope P00004 $554,057
Supplemental Agreement for work within scope P00003 · Non-clnical studies $188,684
Funding Only Action P00002 · Non-clinical studies $61,929
Supplemental Agreement for work within scope P00001 · Non-clnical studies $376,387
Original award $1,544,428
Show all 31

About this award

Written by GovTribe AI ·

The Joint PEO Chemical and Biological Defense issued a $49.5 million cost-plus-fixed-fee delivery order to Battelle Memorial Institute on February 17, 2023, under the Contract Parent Master IDIQ One Acquisition Solution for Integrated Services (OASIS). The $49.5 million figure is the ceiling value, and the order was issued without a set-aside. Its ultimate completion date is February 16, 2028, and place of performance is Columbus, OH 43201.

The award description records a modification to delivery order W911SR-23-F-0049 for studies in support of the CET-RAIDIR program. The modification incorporates an Ebola study under CLIN 0002, approves a BOT MAB manuscript under CLIN 0002, and provides incremental funding to CLIN 0002 and CLIN 0006. Named sub-awards to Illumina, Inc. (OASIS ADRSDR (CET-RAIDR)) and Envigo Global Services Inc. (animals and testing services) support the work, with several additional sub-awardees covering other laboratory and research support.

Subawards

Subcontractor Amount Awarded
Roche Diagnostics Corporation Performance of studies in support of the CET-raidir program. 0000933946 $57,852
Biomodal Inc. PERFORMANCE OF STUDIES IN SUPPORT OF THE CET-RAIDIR PROGRAM. Purchase of Duet multiomics and UDI $72,576
Illumina, Inc. Performance of studies in support of the CET-raidir program. OASIS adrsdr (CET-RAIDR) $125,042
Illumina, Inc. Performance of studies in support of the CET-raidir program. OASIS adrsdr (CET-RAIDR) $69,296
Illumina, Inc. PERFORMANCE OF STUDIES IN SUPPORT OF THE CET-RAIDIR PROGRAM. Technical Supplies $109,141
Envigo Global Services Inc. PERFORMANCE OF STUDIES IN SUPPORT OF THE CET-RAIDIR PROGRAM. Animals and testing services. $499,071
The Geneva Foundation PERFORMANCE OF STUDIES IN SUPPORT OF THE CET-RAIDIR PROGRAM. Evaluation of ERVEBO $2,807,516
Envigo Global Services Inc. TO DESIGN AND CONDUCT NONCLINICAL RESEARCH STUDIES, DEVELOP SUPPORTING ASSAYS AND REAGENTS, INTERPRET AND REPORT STUDY RESULTS AND ANALYSIS, AND EVALUATE… $647,184
IIT Research Institute TO DESIGN AND CONDUCT NONCLINICAL RESEARCH STUDIES, DEVELOP SUPPORTING ASSAYS AND REAGENTS, INTERPRET AND REPORT STUDY RESULTS AND ANALYSIS, AND EVALUATE… $32,000
Envigo Global Services Inc. TO DESIGN AND CONDUCT NONCLINICAL RESEARCH STUDIES, DEVELOP SUPPORTING ASSAYS AND REAGENTS, INTERPRET AND REPORT STUDY RESULTS AND ANALYSIS, AND EVALUATE… $675,929
Trustees Of Boston University PERFORMANCE OF STUDIES IN SUPPORT OF THE CET-RAIDIR PROGRAM. Determine the Efficacy of Obeldesivir, the Oral Remdesivir $1,298,863
Show all 11

Quick answers

Who was awarded contract W911SR23F0049?

W911SR23F0049 was awarded to Battelle Memorial Institute by ACC Aberdeen Proving Ground (Army Contracting Command) on February 16, 2023.

How much is contract W911SR23F0049 worth?

The government has obligated $23,702,221 on W911SR23F0049. Its current value, with exercised options, is $49,500,000.

Which agency awarded contract W911SR23F0049?

ACC Aberdeen Proving Ground (Army Contracting Command) awarded W911SR23F0049, with funding from Joint PEO Chemical and Biological Defense (Acquisition Support Center).

Is contract W911SR23F0049 an order under another contract?

Yes. W911SR23F0049 is a delivery order under GS00Q14OADU402, an indefinite delivery contract, on One Acquisition Solution for Integrated Services (OASIS).

Was contract W911SR23F0049 competed?

The extent of competition for W911SR23F0049 was full and open competition. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login